Tonix Pharmaceuticals Holding Corp.
Stock
Stock
ISIN: US8902608392
Ticker: TNXP
US8902608392
TNXP
Price
Price
CHART BY
Frequently asked questions
What is Tonix Pharmaceuticals Holding Corp.'s market capitalization?
The market capitalization of Tonix Pharmaceuticals Holding Corp. is $330.85M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Tonix Pharmaceuticals Holding Corp.?
Tonix Pharmaceuticals Holding Corp.'s Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$1,006.28. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Tonix Pharmaceuticals Holding Corp.'s stock?
Currently, 2 analysts cover Tonix Pharmaceuticals Holding Corp.'s stock, with a consensus target price of $61.67. Analyst ratings provide insights into the stock's expected performance.
What is Tonix Pharmaceuticals Holding Corp.'s revenue over the trailing twelve months?
Over the trailing twelve months, Tonix Pharmaceuticals Holding Corp. reported a revenue of $9.83M.
What is the EBITDA for Tonix Pharmaceuticals Holding Corp.?
Tonix Pharmaceuticals Holding Corp.'s Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$80.41M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Tonix Pharmaceuticals Holding Corp.?
Tonix Pharmaceuticals Holding Corp. has a free cash flow of -$67.47M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Tonix Pharmaceuticals Holding Corp. have, and what sector and industry does it belong to?
Tonix Pharmaceuticals Holding Corp. employs approximately 81 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of Tonix Pharmaceuticals Holding Corp.'s shares?
The free float of Tonix Pharmaceuticals Holding Corp. is 7.35M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $330.85M
- EPS (TTM)
- -$1,006.28
- Free Float
- 7.35M
- Revenue (TTM)
- $9.83M
- EBITDA (TTM)
- -$80.41M
- Free Cashflow (TTM)
- -$67.47M
Pricing
- 52W span
- $6.77$130.00
Analyst Ratings
The price target is $61.67 and the stock is covered by 2 analysts.
Buy
2
Hold
0
Sell
0
Information
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.
- Employees
- 81
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- US8902608392
- Primary Ticker
- TNXP
Fundamentals & EOD data from FactSet